NOT-HL-22-028: Notice of Additional FOAs for NHLBI participation in NOT-OD-21-100 "Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health"

Notice of Additional FOAs for NHLBI participation in NOT-OD-21-100 "Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health"

Notice Number:

NOT-HL-22-028

Key Dates

Release Date:

June 30, 2022

Related Announcements

NOT-OD-21-100 - Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health

PA-20-260 - PHS 2020 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

PA-20-262 - PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)

PA-20-265 - PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)

PA-20-261 - PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

- The purpose of this Notice is to inform the scientific community that the National Heart, Lung, and Blood Institute (NHLBI) is including additional funding opportunity announcements (FOAs) via NOT-OD-21-100 "Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health".

Current NHLBI FOAs for NOT-OD-21-100 include the following or their subsequent reissued equivalents:

Activity Code	FOA	First Available Due Date
R01	PA-20-183- NIH Research Project Grant (Parent R01 Clinical Trial Required)	June 5, 2021
R01	PA-20-185- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)	June 5, 2021
R01	PAR-19-274- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)	June 5, 2021

New additional FOAs or their subsequent reissued equivalents in bold and italics:

Activity Code	FOA	First Available Due Date
R01	PA-20-183- NIH Research Project Grant (Parent R01 Clinical Trial Required)	June 5, 2021
R01	PA-20-185- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)	June 5, 2021
R01	PAR-19-274- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)	June 5, 2021
*R43/R44*	PA-20-260 - PHS 2020-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed	*September 5, 2021, See reissued FOA for current due dates*
*R43/R44*	*PA-20-262 - PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)*	*September 5, 2021, See reissued FOA for current due dates*
*R41/R42*	*PA-20-265 - PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)*	*September 5, 2021, See reissued FOA for current due dates*
*R41/R42*	*PA-20-261 - PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)*	*September 5, 2021, See reissued FOA for current due dates*

All other aspects of NHLBI's participation remain unchanged.

Inquiries

Please direct all inquiries regarding this Notice to:

Stephanie Davis, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-8412
Email: stephanie.davis3@nih.gov